Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study

Pa Calabresi , Bc Kieseier , Dl Arnold , Lj Balcer , A Boyko , J Pelletier (1) , S Liu , Y Zhu , A Seddighzadeh , S Hung , A Deykin

1 CRMBM - Centre de résonance magnétique biologique et médicale

Domaines: Sciences de l'ingénieur [physics]

Pa Calabresi, Bc Kieseier, Dl Arnold, Lj Balcer, A Boyko, et al.. Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study. The Lancet Neurology, 2014, 13, pp.657-665. ⟨hal-01097451⟩